Crossmark Global Holdings Inc. increased its holdings in Balchem Co. (NASDAQ:BCPC – Free Report) by 20.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,034 shares of the basic materials company’s stock after purchasing an additional 517 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Balchem were worth $534,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the business. Legacy Capital Wealth Partners LLC bought a new stake in shares of Balchem in the third quarter worth $232,000. Atria Investments Inc boosted its position in Balchem by 8.5% during the third quarter. Atria Investments Inc now owns 2,708 shares of the basic materials company’s stock valued at $477,000 after acquiring an additional 212 shares during the last quarter. Fiera Capital Corp bought a new stake in Balchem during the third quarter valued at $4,201,000. Portside Wealth Group LLC boosted its position in Balchem by 12.5% during the third quarter. Portside Wealth Group LLC now owns 1,551 shares of the basic materials company’s stock valued at $273,000 after acquiring an additional 172 shares during the last quarter. Finally, QRG Capital Management Inc. boosted its position in Balchem by 16.3% during the third quarter. QRG Capital Management Inc. now owns 5,186 shares of the basic materials company’s stock valued at $913,000 after acquiring an additional 728 shares during the last quarter. Institutional investors own 87.91% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the stock. HC Wainwright upped their price target on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.
Balchem Price Performance
BCPC stock opened at $177.77 on Friday. The stock has a market capitalization of $5.78 billion, a PE ratio of 47.79, a price-to-earnings-growth ratio of 5.30 and a beta of 0.65. The company’s 50-day moving average is $172.71 and its 200-day moving average is $165.59. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. Balchem Co. has a 1 year low of $120.76 and a 1 year high of $186.03.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Recommended Stories
- Five stocks we like better than Balchem
- What is a Stock Market Index and How Do You Use Them?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is MarketRank™? How to Use it
- Time to Load Up on Home Builders?
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.